Letromina – Anti-Estrogen Drugs

$33.91

Description

Description

Letromina

Specification
Common
Active substanceLetrozole Citrate
IndicationsLetromina is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer
Dosage
Quantity
Unit
Time
Potency
Quantity2,5
UnitMilligram
Packaging
Quantity30
UnitTablet
TypeCarton
PresentationEach carton contains 30 tablets of 2.5mg each